Patent annuity payment services exist because foreign renewal fees fall due annually, in every country separately, on schedules nobody remembers.
In the US it is three payments per patent. That is manageable with a calendar.
Everywhere else it is one per year, per country, per patent — and a four-country family generates twenty deadlines a year before anyone has done anything.
The failure mode is permanent. A missed annuity ends the patent in that jurisdiction, usually without recovery.
What they actually do
| Service | Detail |
|---|---|
| Deadline tracking | Across every jurisdiction in the portfolio |
| Payment execution | Official fees paid on time |
| Currency handling | Conversion and remittance |
| Local agent coordination | Where a local representative is required |
| Reminders and instruction requests | Before each payment |
| Reporting | Status and forecast |
| Fee forecasting | Budgeting across years |
Fee forecasting is undervalued at selection and used constantly afterwards. Projecting three years of annuities across a portfolio, at the correct entity rate and in the right currencies, is what turns a docket into a budget.
They do not decide what to renew. That is a commercial judgement and it stays with you.
When you need one
| Portfolio | Approach |
|---|---|
| Under 10 US patents | Calendar — three fees each |
| 10–50 US only | Calendar plus docketing discipline |
| Any foreign portfolio | Service — annual deadlines per country |
| 50+ rights | Service |
| Multi-jurisdiction, 100+ | Service, with a named internal owner |
The threshold is jurisdictions, not patent count. Twenty US patents generate sixty deadlines across a decade; twenty patents across five countries generate hundreds.
Pendency matters too. Many countries charge annuities while an application is pending, unlike the US, so foreign filings start generating deadlines years before grant. See patent annuity.
How they charge
| Model | Detail | Watch for |
|---|---|---|
| Flat fee per payment | Simple, predictable | Adds up across a large portfolio |
| Percentage of the official fee | Scales with fee size | Expensive on large annuities |
| Portfolio subscription | Fixed annual | What is in and out of scope |
| Currency conversion margin | On every foreign payment | Easy to overlook, real money |
| Local agent charges | Passed through | Whether marked up |
Compare the total cost of a representative year, not the headline per-payment fee. Conversion margins and agent pass-throughs frequently exceed the service fee itself.
Ask for a worked quote on your actual portfolio. A per-payment figure tells you little without knowing how many payments and in which currencies.
What the insurance covers
| Scenario | Typically covered? |
|---|---|
| Provider misses a payment through their error | Yes |
| Provider pays the wrong amount | Usually |
| Provider pays for the wrong patent | Usually |
| You instruct late | No |
| You give a wrong instruction | No |
| You decide to lapse and change your mind | No |
| Patent office error | Varies |
| Consequential loss beyond the patent value | Usually excluded |
Insurance covers their mistakes, not yours. That distinction is the whole of the cover and it is worth reading the policy summary rather than the marketing line.
Ask what the limit is and whether it is per patent or aggregate across a year. An aggregate limit shared across all clients behaves differently from a per-patent one.
Verifying a payment
A provider confirmation is a report. The patent office record is evidence.
| Jurisdiction | Where to verify |
|---|---|
| United States | USPTO Patent Center — maintenance fee status |
| Europe | EPO register |
| Others | National office registers |
Check a sample every cycle, not every payment. Spot-checking five per quarter catches a systemic problem quickly and costs almost nothing.
Check all of them after switching providers, and after any change in your own instruction process.
This is the single habit that separates portfolios that lapse by accident from those that do not.
What good instruction handling looks like
| Practice | Why |
|---|---|
| Instruction request 3+ months ahead | Leaves room to decide, and to sell |
| Reminder if unanswered | Catches inbox failures |
| Escalation to a named person | Prevents silent lapses |
| Default stated explicitly | You know what happens if you say nothing |
| Confirmation after payment | With an office reference |
| Annual forecast | Budgeting |
The default matters most. A provider whose default is to pay protects against lapse and costs money on patents you would have released. One whose default is to lapse does the reverse.
Know which yours is, and set it deliberately rather than discovering it.
The questions that separate providers
| Ask | Weak answer |
|---|---|
| Which jurisdictions do you cover directly? | "Global" |
| Which use local agents, and are charges marked up? | Unclear |
| What is the insurance limit, and per patent or aggregate? | Vague |
| Do you pay before the grace period or during it? | "Within the grace period" |
| What happens if I do not respond to an instruction request? | "We let it lapse" without escalation |
| How do you handle entity status? | "We use what you gave us" without prompting review |
| Can I export my full deadline data? | Restricted |
| What is your escalation path near a deadline? | No named contact |
Paying before the grace period rather than during it is the important one. Grace periods are a safety margin. A provider that routinely uses them has spent your margin as a matter of process.
Escalation on non-response matters. An instruction request that goes unanswered should trigger a phone call, not a lapse.
Cost against exposure
| Portfolio | Annual service cost | Exposure if one lapse occurs |
|---|---|---|
| 20 foreign rights | Modest | The full value of one patent |
| 100 rights | Meaningful | Same, more often |
The arithmetic favours the service almost always, because the cost is proportional to payments and the loss is proportional to asset value.
What stays with you
| Task | Why |
|---|---|
| The renewal decision | Commercial judgement, not administration |
| Entity status determination | A judgement about your own circumstances |
| An independent deadline record | Outsourcing execution is not outsourcing consequence |
| Verification against office records | Takes minutes, catches everything |
| Instructing on time | The uninsured failure |
Entity status is the trap. A service applies the status you tell them. Growth past 500 employees, or a licence to a large company, ends small entity eligibility, and paying at a reduced rate when no longer entitled can render a patent unenforceable. See small entity status.
Keep your own calendar. If the service fails, your record is the backstop.
Worked example: a portfolio in one year
28 patents across the US, EP, CN and JP.
| Jurisdiction | Rights | Payments per year |
|---|---|---|
| US | 12 | ~4 (three fees over a life) |
| EP validations | 8 | 8 annual |
| China | 5 | 5 annual |
| Japan | 3 | 3 annual |
| Total annual deadlines | ~20 |
| Cost element | Annual |
|---|---|
| Official fees | Varies by year and stage |
| Service fees, ~20 payments | Per-payment × 20 |
| Currency conversion margins | On 16 foreign payments |
| Local agent pass-throughs | Where required |
Sixteen of the twenty deadlines are foreign and annual. That is the case for using a service in a single line.
The conversion margin applies sixteen times a year, which is why comparing only the per-payment fee understates the difference between providers.
Data quality at onboarding
| Field | Common error |
|---|---|
| Patent and application numbers | Transcription |
| Jurisdiction and stage | Pending vs granted mismatched |
| Entity status | Carried over stale |
| Owner of record | Out of date after an assignment |
| Priority dates | Wrong parent in a family |
| Local agent of record | Missing |
Onboarding is where systemic errors enter. Every deadline calculated afterwards inherits whatever was loaded, and an error in a priority date propagates silently for years.
Verify the loaded data against office records once, at onboarding, patent by patent. It is tedious and it is the only point where the whole set is checked at once.
Recorded ownership matters for foreign filings. Several jurisdictions require the recorded owner to match, and an unrecorded assignment can block a payment at the deadline.
The decision the service does not make
Every deadline is a decision, not an invoice.
| Ipiry Patent Survival Curve v1.0 | Rate |
|---|---|
| Survive the 3.5-year fee (2022 cohort) | 85.8% |
| Survive the 7.5-year fee (2018 cohort) | 64.6% |
| Reach full term (2014 cohort) | 41.4% |
| Abandoned before full term | 58.6% |
Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.
Nearly three in five US utility patents are deliberately allowed to lapse. A service that pays everything by default converts a portfolio review into a standing order.
Set instruction requests to arrive early enough to decide, at least three months before the deadline, so selling remains an option. See patent portfolio management.
Reporting to ask for
| Report | Frequency |
|---|---|
| Upcoming deadlines, 12 months | Monthly |
| Fee forecast by year and currency | Annual |
| Payments made, with office references | Per cycle |
| Portfolio by jurisdiction and status | Quarterly |
| Exceptions — unanswered instructions | Immediate |
The exceptions report is the one that prevents lapses. Everything else is useful; that one is protective.
Switching providers
| Step | Risk |
|---|---|
| Export deadline data | Check the format is usable |
| Verify every deadline against office records | Not against the old provider |
| Confirm entity status carried across correctly | Common error |
| Run both in parallel for one cycle | Recommended |
| Never switch near a deadline | Obvious and frequently ignored |
Verify against the patent office, not the outgoing provider. If their data was wrong, the migration faithfully reproduces the error.
Parallel running for one cycle is tedious and cheaper than a lapse.
Patent annuity payment services: the checklist
- Use one for any foreign portfolio. Annual deadlines per country exceed manual tracking quickly.
- Compare total annual cost, including conversion margins and agent pass-throughs.
- Read what the insurance covers. Provider error yes; your late instruction no.
- Ask whether they pay before or during the grace period. Before is the right answer.
- Confirm the escalation path when an instruction request goes unanswered.
- Verify payments against patent office records, not provider confirmations.
- Spot-check five payments per quarter. It catches systemic problems early.
- Keep entity status determination in-house and review it at every payment.
- Keep your own independent deadline calendar regardless of who executes.
- Set instruction requests three months out, so each deadline is a decision and selling stays possible.